Pharminent

Pfizer anchoring inflammation hopes in Xeljanz

After a slow launch, the RA drug is picking up speed, leading the big pharma to invest in growing it further.  http://www.biopharmadive.com/news/pfizer-anchoring-inflammation-hopes-in-xeljanz/428643/

Filed under: Arthritis